Utrecht Coronary Biobank (UCORBIO)

UMC Utrecht3,000 enrolled

Overview

UCORBIO enrolls patients who undergo coronary angiography (for any indication). The investigators draw blood at the moment of insertion of the procedural arterial catheter. At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed. Patients are then followed-up for the occurrence of major adverse cardiovascular events for 5 years. During the follow-up period patients receive a questionnaire every year to check for hospital admissions. The questionnaires at two and five years of follow-up are enriched with quality of life questionnaires (RAND-36 and EuroQoL).

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Coronary Artery Disease

Interventions

Observational study, no intervention.OTHER

Observational study, no intervention.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Coronary angiography Exclusion Criteria: * Age \< 18 years.

Locations (1)

UMC Utrecht

Utrecht, Utrecht, Netherlands

Outcomes

Primary Outcomes

major adverse cardiovascular events [MACE] (Stroke, myocardial infarction, coronary revascularization, death)

Stroke, myocardial infarction, coronary revascularization, death.

Time frame: 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.